search
Back to results

Study Designed to Optimize the Treatment of Primary Pneumothorax (TOPP)

Primary Purpose

Primary Spontaneous Pneumothorax, Pleural Disease

Status
Recruiting
Phase
Early Phase 1
Locations
Denmark
Study Type
Interventional
Intervention
VATS bullectomy and mechanical pleuradesis.
Chest tube insertion
Epidural
High-resolution Computer Tomography
Sponsored by
Odense University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Primary Spontaneous Pneumothorax focused on measuring primary spontaneous pneumothorax, epidemiology, genetics, risk factors

Eligibility Criteria

18 Years - 40 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • First incidence of primary spontaneous pneumothorax.
  • Age between 18 and 40.
  • No known preexisting pulmonary disease.
  • Patient must accept randomization.
  • Able to read and understand information regarding the study.
  • The condition must require treatment with a chest-tube.

Exclusion Criteria:

  • Age above 40.
  • Previously pulmonary og cardiac surgery.
  • Pregnant or breastfeeding.
  • Patients who do not tolerate anesthetics.

Sites / Locations

  • Research Unit at the cardiothoracic departement at the University Hospital of OdenseRecruiting
  • Research Unit at the Cardiothoracic Department at the University Hospital of SkejbyRecruiting
  • Research Unit at the Cardiothoracic Department af Ålborg HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Experimental

Arm Label

HRCT with bullae, treatment conservative

HRCT no bullae, treatment conservative

HRCT with bullae, treatment VATS.

HRCT no bullae, treatment VATS.

Arm Description

Patients undergo High-resolution CT scan, and significant bullae are identified (i.e. > 1 cm). Afterwards randomised to conservative treatment with conventional chest-tube drainage.

Patients undergo High-resolution CT scan, and no significant bullae are identified (i.e. > 1 cm). Afterwards randomised to conservative treatment with conventional chest-tube drainage.

Patients undergo High-resolution CT scan, and significant bullae are identified (i.e. > 1 cm). Afterwards randomised to active treatment with VATS bullectomy and mechanical pleurodesis.

Patients undergo High-resolution CT scan, and no significant bullae are identified (i.e. > 1 cm). Afterwards randomised to active treatment with VATS bullectomy and mechanical pleurodesis.

Outcomes

Primary Outcome Measures

Time to ipsilateral recurrence
All participants are followed 10 years from the initial discharge via Questionnaires

Secondary Outcome Measures

Number of Participants with Adverse Events as a Measure of Safety and Tolerability
Length of hospital stay
Length of initial hospital stay
Pain according to NRS scale reported at discharge, at 4 weeks, 1 year, 5 years and 10 years.

Full Information

First Posted
August 9, 2010
Last Updated
August 14, 2016
Sponsor
Odense University Hospital
Collaborators
Danish Medical Association, Danmarks Lungeforening
search

1. Study Identification

Unique Protocol Identification Number
NCT02866305
Brief Title
Study Designed to Optimize the Treatment of Primary Pneumothorax
Acronym
TOPP
Official Title
Thoracoscopic Treatment of Primary Pneumothorax - A National Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2016
Overall Recruitment Status
Recruiting
Study Start Date
March 2009 (undefined)
Primary Completion Date
December 2017 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Odense University Hospital
Collaborators
Danish Medical Association, Danmarks Lungeforening

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Knowledge about incidence, risk factors and genetic predispositions of primary spontaneous pneumothorax in young adults is very limited, and treatment has also been controversial.The Aim of this study is to optimize the treatment, estimate the actual incidence, and identify possible risk factors including genetic predispositions.
Detailed Description
Background Knowledge about incidence, risk factors and genetic predispositions of primary spontaneous pneumothorax in young adults is very limited, and treatment has also been controversial. Typically, the first incidence is treated conservatively with simple chest tube drainage and only if the disease reoccurs is surgery considered. However, conventional treatment may be associated with increased morbidity, prolonged hospitalization and many young adults are concerned about the high recurrence of this disease. The latter has been reported in as many as 25-35% of patients. Because spontaneous pneumothorax in young adults usually is associated with apical blebs, the investigators hypothesized that primary surgery (Video-Assisted Thoracoscopic Surgery = VATS) with resection of such blebs at the time of the first episode of pneumothorax might be an effective first line treatment associated with lower morbidity and shorter hospital stays, and a definite decline in recurrence rate. Method From July 2009 the investigators conducted a nationwide study , where 300 consecutive patients admitted to a Danish hospital with primary spontaneous pneumothorax undergo a high resolution CT of the thorax. Based upon the CT the patients are randomised to conventional conservative treatment (chest tube drainage) or primary VATS with bleb resection and mechanical pleurodesis. Participants are followed for ten years. The primary endpoint is ipsilateral recurrence of pneumothorax. Secondary endpoints are length of hospitalization, duration of chest tube drainage and miscellaneous complications. Simultaneously, a research biobank containing blood samples and pulmonary tissue is created for future studies of biomarkers and possible genetic causes. Finally, the investigators are conducting a national epidemiological study, where the incidence in the Danish population is investigated. *Perspective This study contributes new knowledge on incidence, genetics and best treatment of primary spontaneous pneumothorax in young adults which will have an impact on the future strategy of both understanding and treatment of this disease on a global level.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Primary Spontaneous Pneumothorax, Pleural Disease
Keywords
primary spontaneous pneumothorax, epidemiology, genetics, risk factors

7. Study Design

Primary Purpose
Treatment
Study Phase
Early Phase 1
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
300 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
HRCT with bullae, treatment conservative
Arm Type
Experimental
Arm Description
Patients undergo High-resolution CT scan, and significant bullae are identified (i.e. > 1 cm). Afterwards randomised to conservative treatment with conventional chest-tube drainage.
Arm Title
HRCT no bullae, treatment conservative
Arm Type
Experimental
Arm Description
Patients undergo High-resolution CT scan, and no significant bullae are identified (i.e. > 1 cm). Afterwards randomised to conservative treatment with conventional chest-tube drainage.
Arm Title
HRCT with bullae, treatment VATS.
Arm Type
Experimental
Arm Description
Patients undergo High-resolution CT scan, and significant bullae are identified (i.e. > 1 cm). Afterwards randomised to active treatment with VATS bullectomy and mechanical pleurodesis.
Arm Title
HRCT no bullae, treatment VATS.
Arm Type
Experimental
Arm Description
Patients undergo High-resolution CT scan, and no significant bullae are identified (i.e. > 1 cm). Afterwards randomised to active treatment with VATS bullectomy and mechanical pleurodesis.
Intervention Type
Procedure
Intervention Name(s)
VATS bullectomy and mechanical pleuradesis.
Intervention Description
Thoracoscopic bullectomy is performed on all visible bullae, alternatively is no visible bullae, the apex is resected. Then mechanical pleuradesis is performed.
Intervention Type
Procedure
Intervention Name(s)
Chest tube insertion
Intervention Description
Conventional chest tube insertion.
Intervention Type
Drug
Intervention Name(s)
Epidural
Other Intervention Name(s)
Pain- catheter
Intervention Description
All surgical participants received an epidural prior to the procedure.The epidural was removed simultaneous with the the chest tube.
Intervention Type
Radiation
Intervention Name(s)
High-resolution Computer Tomography
Intervention Description
All participants included in this study had a HRCT performed.
Primary Outcome Measure Information:
Title
Time to ipsilateral recurrence
Description
All participants are followed 10 years from the initial discharge via Questionnaires
Time Frame
10 years
Secondary Outcome Measure Information:
Title
Number of Participants with Adverse Events as a Measure of Safety and Tolerability
Time Frame
10 years
Title
Length of hospital stay
Description
Length of initial hospital stay
Time Frame
up to 10 years
Title
Pain according to NRS scale reported at discharge, at 4 weeks, 1 year, 5 years and 10 years.
Time Frame
up to 10 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: First incidence of primary spontaneous pneumothorax. Age between 18 and 40. No known preexisting pulmonary disease. Patient must accept randomization. Able to read and understand information regarding the study. The condition must require treatment with a chest-tube. Exclusion Criteria: Age above 40. Previously pulmonary og cardiac surgery. Pregnant or breastfeeding. Patients who do not tolerate anesthetics.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Winnie Hedevang Olesen, ph.d.student
Phone
0045-22947131
Email
winnie.olesen@rsyd.dk
First Name & Middle Initial & Last Name or Official Title & Degree
Peter Bjørn Licht, Professor
Phone
0045-65413385
Email
peter.licht@ouh.regionsyddanmark.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Winnie Hedevang Olesen, ph.d.student
Organizational Affiliation
Research Unit at the Cardiothoracic Department at the University Hospital of Odense.
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Peter Bjørn Licht, Professor MD
Organizational Affiliation
Research Unit at the Cardiothoracic Department at the University Hospital of Odense
Official's Role
Principal Investigator
Facility Information:
Facility Name
Research Unit at the cardiothoracic departement at the University Hospital of Odense
City
Odense
State/Province
Fyn
ZIP/Postal Code
5690
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Winnie Hedevang Olesen, ph.d.student
Phone
0045-22947131
Email
winnieholesen@rsyd.dk
First Name & Middle Initial & Last Name & Degree
Peter Bjørn Licht, Professor
Phone
0045-65413385
Email
peter.licht@ouh.regionsyddanmark.dk
First Name & Middle Initial & Last Name & Degree
Winnie Hedevang Olesen, ph.d.student
First Name & Middle Initial & Last Name & Degree
Peter Bjørn Licht, Professor
Facility Name
Research Unit at the Cardiothoracic Department at the University Hospital of Skejby
City
Århus
State/Province
Midtjylland
ZIP/Postal Code
8600
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Niels Katballe, MD, ph.d.
Facility Name
Research Unit at the Cardiothoracic Department af Ålborg Hospital
City
Ålborg
State/Province
Nordjylland
ZIP/Postal Code
9100
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jesper Eske Sindby, resident

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
29509892
Citation
Olesen WH, Katballe N, Sindby JE, Titlestad IL, Andersen PE, Lindahl-Jacobsen R, Licht PB. Surgical treatment versus conventional chest tube drainage in primary spontaneous pneumothorax: a randomized controlled trial. Eur J Cardiothorac Surg. 2018 Jul 1;54(1):113-121. doi: 10.1093/ejcts/ezy003.
Results Reference
derived

Learn more about this trial

Study Designed to Optimize the Treatment of Primary Pneumothorax

We'll reach out to this number within 24 hrs